Epidermolysis bullosa (EB) is a heterogeneous group of rare genetic ... the level of blistering within the dermal-epidermal junction, namely, EB simplex (EBX), junctional EB (JEB) and dystrophic EB ...

A spokesperson for the Consumer Healthcare Products Association—an organization that represents the over-the-counter medicine industry—told National Geographic that “it’s important to ...

Junctional epidermolysis bullosa ( JEB) is a variant of EB where ... University of Miami School of Medicine, Miami, FL. Alyssa Feiner, MD, is a Medical Student, University of Miami School of ...

1 The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People’s Hospital ... China Background: Dystrophic epidermolysis bullosa (DEB) is a hereditary disease ...

Eddie Vedder wrote the music for and participates in "Matter of Time," a documentary premiering at Tribeca Film Festival about the fight to cure the rare disease epidermolysis bullosa. A powerful ...

Dermaliq Therapeutics and global non-profit organisation DEBRA Research have entered into a partnership aimed at advancing drug delivery into the skin for epidermolysis bullosa (EB). The non-exclusive ...

A scroll through any streaming service already yields a flood of music-centric films, but prepare for a new surge this year. From durable veteran to blazing trendsetter, there’s a music ...

“Rigosertib is available for further development and commercialization, and we are committed to finding an appropriate partner to advance this important medicine to approval.” About RDEB ...

We performed a phase 3 trial involving women 18 to 70 years of age with moderate-to-severe vasomotor symptoms associated with endocrine therapy for HR-positive breast cancer or its prevention ...

There is no cure for the disease, which affects at least 5,000 people in the UK and 500,000 worldwide. Ten to 15 per cent of Abe's body is always covered in wounds. (Photo courtesy of Alex Hersham ...

Initial programs will focus on developing innovative topical treatments and drug therapies for wound healing and itch relief, plus prophylactic therapies for people with Epidermolysis Bullosa.